Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cataract, cost: curious questions.

D J Moran1

  • 1fhf@hollows.com.au

Australian and New Zealand Journal of Ophthalmology
|March 18, 1999
PubMed
Summary
This summary is machine-generated.

Australian healthcare pricing for implantable prosthetic devices is artificially inflated, allowing private hospitals and doctors to profit significantly. This governmental pricing mechanism needs urgent review due to high costs and increasing device usage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal plasma progesterone levels fall after rectal administration of estriol.

The Journal of clinical endocrinology and metabolism·1994
Same author

Lysosome-associated membrane protein-1 (LAMP-1) is the melanocyte vesicular membrane glycoprotein band II.

The Journal of investigative dermatology·1993
Same author

Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis.

The Journal of investigative dermatology·1993
Same author

Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation.

American journal of obstetrics and gynecology·1992
Same author

Calcium in the developing Ambystoma neural axis shown by 3H and fluorescent chlortetracycline and atomic absorption spectrometry.

The Anatomical record·1990
Same author

White noise and sleep induction.

Archives of disease in childhood·1990
Same journal

Thomas a'Beckett Travers, 1902-1999.

Australian and New Zealand journal of ophthalmology·2000
Same journal

Bowen's disease of the eyelid in a renal transplant recipient on immunosuppressants.

Australian and New Zealand journal of ophthalmology·2000
Same journal

Linear IgA disease.

Australian and New Zealand journal of ophthalmology·2000
Same journal

Ring keratitis from topical anaesthetic misuse.

Australian and New Zealand journal of ophthalmology·2000
Same journal

Lamellar corneal autograft for corneal perforation.

Australian and New Zealand journal of ophthalmology·2000
Same journal

Preretinal haemorrhages: an unusual manifestation of intravitreal amikacin toxicity.

Australian and New Zealand journal of ophthalmology·2000
See all related articles

Area of Science:

  • Health economics
  • Medical device regulation
  • Public health policy

Background:

  • Australian governmental mechanisms inflate prices for 7500 listed implantable prosthetic devices.
  • These prices are unacceptably high compared to international benchmarks.
  • Even open market prices for items like intra-ocular lenses exceed global standards.

Discussion:

  • Private hospitals and medical practitioners legally exploit inflated pricing for profit.
  • This practice occurs within a context of strained health budgets and rising device utilization.
  • The current system permits significant markups from market to inflated prices.

Key Insights:

  • A systemic issue exists in Australia regarding the pricing of implantable medical devices.
  • Profitability for providers is legally embedded within an artificially high pricing structure.

Related Experiment Videos

  • International price comparisons highlight the extent of the inflation.

    • Outlook:

    • Urgent policy intervention is required to address the pricing of prosthetic devices.
    • Reforms are necessary to align Australian prices with global standards.
    • Addressing these issues is crucial for sustainable healthcare spending and patient access.